ASXL1 and chronic myelomonocytic leukemia: Recently, Patnaik et al. reported a prognostic interaction between ASXL1 and TET2 mutations in CMML [6], confirming the negative impact in OS imparted by ASXL1 mutations and suggesting a favorable impact from TET2 mutations in the absence of ASXL1 mutations.